A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma

NCT00924989 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

139

Enrollment

INDUSTRY

Sponsor class

Conditions

Adrenocortical Carcinoma

Interventions

DRUG: OSI-906
OTHER: Placebo

Sponsor

Astellas Pharma Inc